课题基金 / 基金详情

As to the orgin of the disease-causing gene of the Japanese-type adenine phosphoribosyltransferase deficiency

As to the orgin of the disease-causing gene of the Japanese-type adenine phosphoribosyltransferase deficiency
关于日本型腺嘌呤磷酸核糖转移酶缺乏症的致病基因的来源
批准号:
61480484
负责人:
KAMATANI Naoyuki
金额:
$4.48万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1987

项目摘要

项目成果

KAMATANI Naoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Adenine phosphoribosyltransferase (APRT) deficiency is a genetic disease characterized by reccurrent urolithiatic episodes and renal insufficiency. This disease is especially common among Japanese at least partially because Japanese, as an ethnical group, have a special type of the disease designated as "the Japanese-type APRT deficiency" as we havev previously clarified. The original aim of the present project to clarify the origin of the disease-causing gene of the Japanese-type APRT deficiency has almost completely achieved. Thus, we have identified the gene responsible for this disease (APRT*J), identidied a nucleotide substitution in this gene (in exon 5), and also identified an amino acid substitution in the Japanese-type APRT enzyme (Met to Thr at position 136). Furthermore, we confirmed that this nucleotide and amino acid substitution are present in all the separate families with the Japanese-type APRT deficiency. We have devised a new diagnostic method identifying the amono ac … More id substitution seen in the Japanese-type mutant enzyme. In addition to the mutation specific for the Japanese-type APRT deficiency, we found a nucleotide substitution in intron 2. Based on the data about this restriction fragment length polymorphism, we provided confidential evidence that the disease-causing genes in separate families with the Japanese-type APRT deficiency derived from a sngle ancestor gene which was created in an ancestor of Japanese. Besides the orginal aim of the present project, we have been able to obtain some valuable results. First, we have diagnosed more than half of all the patients with APRT deficiency in the world. Second, we found that as much as 80% of all the families with APRT deficiency in Japan were classified as the Japanese-type. Therefore, the fact that APRT deficiency is especially common among Japanese is, at least in part, explained by the wide distribution of this mutant gene (APRT*J) among Japanese (but not among Caucacians). Third, we found most of the patients with APRT deficiency had not been properly diagnosed, and our report as to this disease will be benificial to many patients with this disease. We confirm that the evidence for a common ancestor disease-causing gene for as much as 80% of all the patients with a single disease in an ethnical group will affect thories of evolution, and will be against the concept of eugenics that has affected even laws of many modern countries. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Hidaka,Y., Tarle,S.A., Fujimori,S., Kamatani,N., et al.: "Human adenine phosphoribosyltrnasferase (APRT) deficiency: Demonstration of a single mutant allele common to the Japanese" J. Clin. Invest.
Hidaka,Y.、Tarle,S.A.、Fujimori,S.、Kamatani,N. 等人:“人腺嘌呤磷酸核糖转移酶 (APRT) 缺陷:日本人常见的单一突变等位基因的演示”J. Clin。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nobori,T.;Yamanaka,H.;Kamatani,N.,et al.: Purine Metabolism in Man-【V】,Plenum,New York. 5. 35-38 (1986)
Nobori,T.;Yamanaka,H.;Kamatani,N.,等人:人类的嘌呤代谢-【V】,Plenum,纽约。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kamatani, N;Yamanaka, H.;Nobori, T. et al.: Purine Metabolism in Man-V. 5. 39-46 (1986)
Kamatani, N;Yamanaka, H.;Nobori, T. 等人:Man-V 中的嘌呤代谢。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kamatani, N.;Kuroshima, S.;Terai, C. et al.: Hum. Genet.76. 148-152 (1987)
Kamatani, N.;Kuroshima, S.;Terai, C. 等人:嗯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
23
    Molecular studies on genomic imprinting at APRT locus
    • 批准号:
      07457127
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $2.05万
    • 财政年份:
      1995
    • 负责人:
      KAMATANI Naoyuki
    • 依托单位:
    海外基金